Biotech Values

[daved]

They will charge a lot for MC 1 IMHO.

They've had a stretched out patent strategy in place for a long time.

Regardless of whether B6 would work just as well surgeons simply could not risk it without extensive clinical data supporting that decision.

Remember MCU is spending 35+ mil on the P3 alone.

Dave